Canary Biotech

Canary Biotech is dedicated to advancing the field of biotechnology research, with a focus on innovative solutions that improve accessibility and convenience in prenatal genetic testing. Canary Biotech is committed to making advanced diagnostic tools available to a wider audience, starting with its pioneering at-home test for fetal DNA detection in maternal urine. This groundbreaking approach aims to provide early gender detection by identifying the Y chromosome in urine as early as 10 weeks of gestation, offering a safe and comfortable alternative to traditional methods.

Canary Biotech's mission is to transform prenatal care through cutting-edge technology. Located in Naharia, IL, Canary Biotech is developing solutions that reduce costs and eliminate the need for specialized sample collection and processing. By leveraging its expertise in biotechnology, Canary Biotech is poised to revolutionize the way expectant parents access critical genetic information.

Canary Biotech envisions a future where prenatal genetic testing is seamlessly integrated into routine healthcare, empowering families with the knowledge they need to make informed decisions. We invite the manager of Canary Biotech to enhance the company's presence on our platform by creating a customized and exclusive company showcase and product listing.